Healthcare -
Biotechnology - NASDAQ - US
$ 0.5755
2.97 %
$ 168 M
Market Cap
-0.73
P/E
LYEL - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss LYEL - Lyell Immunopharma, Inc.
-94 K
LAST VALUE
75.93%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR